← Open Payments lookup

CLAUDIO CABREJOS: Open Payments

NPI 1033133483 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,156 in 49 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $774 · 2025 $1,156

Food & beverage: $1,156
CompanyPaymentsAmount
Alkermes, Inc.10$301
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$269
Vanda Pharmaceuticals Inc.5$162
Lundbeck LLC4$81
Neurocrine BioSciences, Inc.2$65
E.R. Squibb & Sons, L.L.C.2$49
Supernus Pharmaceuticals, Inc.2$44
Otsuka America Pharmaceutical, Inc.2$44
Janssen Pharmaceuticals, Inc2$43
ABBVIE INC.2$43

Products named: CAPLYTA, ARISTADA, HETLIOZ, LYBALVI, REXULTI, INGREZZA, COBENFY, Qelbree.

Industry payments across CA — which companies pay providers there.